Tonix Pharmaceuticals Holding Corp.(NASDAQ : TNXP)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMRN | Amarin Corp. Plc | 1.28% | 20.52 | 1.7% | $278.90m | |
| MDCO | The Medicines Co. | -1.18% | 69.76 | 20.2% | $168.39m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 0.07% | 27.75 | 14.1% | $163.28m | |
| BHC | Bausch Health Cos., Inc. | 0.07% | 27.75 | 0.0% | $112.98m | |
| GWPH | GW Pharmaceuticals Plc | 0.15% | 99.36 | 6.2% | $88.17m | |
| JAZZ | Jazz Pharmaceuticals Plc | 1.41% | 142.63 | 2.3% | $73.22m | |
| SAGE | SAGE Therapeutics, Inc. | 0.17% | 151.78 | 8.6% | $57.27m | |
| PRGO | Perrigo Co. Plc | -0.14% | 48.62 | 6.8% | $55.84m | |
| UTHR | United Therapeutics Corp. | -1.51% | 93.40 | 14.3% | $43.16m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.51% | 87.90 | 16.9% | $42.69m | |
| HZNP | Horizon Therapeutics Plc | -0.86% | 31.00 | 6.6% | $41.06m | |
| ICLR | ICON plc | -0.79% | 155.15 | 4.2% | $39.09m | |
| ENDP | Endo International Plc | -2.57% | 4.55 | 8.8% | $34.21m | |
| CTLT | Catalent, Inc. | -0.12% | 51.54 | 2.4% | $33.45m | |
| AXSM | Axsome Therapeutics, Inc. | 4.31% | 34.12 | 2.0% | $28.84m |
Company Profile
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions, to improve biodefense through potential medical counter-measures, to treat transplant rejection and to treat gastric and pancreatic cancers. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.